Who will be the next Medtronic? What will be Minnesota's next breakthrough industry? James Walsh will provide the latest information and commentary on the people, companies and trends driving innovation in Minnesota. From visionary entrepreneurs to game changing technologies, this blog offers a window into the future of Minnesota's economy.

Boston Sci device gains CE Mark to treat dystonia

Posted by: James Walsh under Minnesota technology Updated: November 19, 2013 - 5:17 PM

Boston Scientific’s Vercise Deep Brain Stimulation (DBS) System has received CE Mark approval for the treatment of intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions, the company reported Tuesday.

Dystonia affects more than 500,000 people across Europe. It is the third most common movement disorder after Parkinson's disease and essential tremor. Symptoms include involuntary muscle contractions, which can be painful and debilitating.  Boston Scientific says the Vercise DBS System is the first system designed to selectively stimulate targeted areas of the brain in order to customize therapy and manage symptoms of Parkinson's disease.  This system now offers treatment for patients with dystonia.  

"Historically, treatment of secondary dystonia has been challenging and efficacy was typically incomplete and partially limited by side effects.  The Vercise DBS system represents an advancement in dystonia care by providing more flexible and unique programming options for targeted deep brain stimulation tailored to each individual," said Prof. Dr. Andrea Kühn.

For more information, go to:  http://www.bostonscientific.com

  • 0
  • Comments

Be the first to comment

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT